Regular insulin
Dilution requiredFull monograph review pending
Historical dilution reference. Verify the preparation against the label for the product in hand.
Original GlobalRPh article: Insulin (regular) (opens in a new tab)Original source URL: https://globalrph.com/dilution/insulin-regular/ Retrieved 2026-11-04
Historical source details
Original publication date: unavailable in the retrieved article.
Source location and file checksums
- Original source URL
- https://globalrph.com/dilution/insulin-regular/ (opens in a new tab)
- Source date
- Not established in the retrieved source
- Retrieved
- 2026-11-04T19:49:26.880780+00:00
- Source location
- div.post-content
- Packaged content SHA-256
- a2b5b069680ea4ba8cef5a2ccc0bf3ce90f3ebfa062ec5ac9414a73f6afa3579
- Original response SHA-256
- d99491a293b06fa2b5db28aadcea3fad2a48bd655ee091fc4d64944f26ee32eb
- Source body SHA-256
- 80437df13202ff632558c7e6a0b257696ccf90431e3edb643b096230a216506d
Insulin (regular) |
| The authors make no claims of the accuracy of the information contained herein; and these suggested doses and/or guidelines are not a substitute for clinical judgment. Neither GlobalRPh Inc. nor any other party involved in the preparation of this document shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user's use of or reliance upon this material. PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER. |
Usual Diluents |
| NS |
Standard Dilutions [Amount of drug] [Infusion volume] [Infusion rate] |
| Usual final concentrations: 0.5 unit/ml or 1 unit/ml (ICU's only - Detroit VAMC) |
Stability / Miscellaneous |
| EXP: 1 DAY (RT/REF) |
U.S. label preparation
Humulin R U-100 multiple-dose vial · Dilution required
- Preparation
- For an IV infusion, prepare regular human insulin at 0.1 to 1 unit/mL in an infusion system containing 0.9% sodium chloride. These instructions apply only to the U-100 vial.
- Administration and handling
- Administer under medical supervision with close monitoring of blood glucose and potassium. The sterile insulin diluent described for subcutaneous injection is for that route only.
Product and source details
Eli Lilly and Company · BLA018780
Product NDC: 0002-0213, 0002-8215
SPL effective 2026-06-16 | SPL version 35. Checked 2026-11-13.
Source for this summary: U.S. prescribing information. Use the full label for dose selection, contraindications, preparation tables and monitoring.
Product identifiers and clinical review status
U.S. label preparation available. Full monograph review pending.
Selected product identity
The selected product is identified for this preparation.
View product identifiers and primary-label provenance
- Selected product scope
- Humulin R U-100 multiple-dose vial
- Labeler
- Eli Lilly and Company
- Application number(s)
- BLA018780
- NDC(s)
- 0002-0213; 0002-8215
- DailyMed Set ID
- b519bd83-038c-4ec5-a231-a51ec5cc291f
- SPL version
- 35
- Label printed revision date
- Not established
- SPL effective date
- 2026-06-16
- Retrieved
- 2026-11-13
- Downloaded XML SHA-256
- 725b535bcb3b23344295414cbad7c3eef306a46c9a6366b31b172ce3bd0eb397
Selected label Humulin R U-100 multiple-dose vial
What remains to be completed
- Obtain independent corroboration of the label preparation where available.
- Complete indication- and age-specific dosing, incompatibility, monitoring and stability review.
- Assess any proposed compounding BUD for the exact formulation, concentration, container and conditions.
Open the original GlobalRPh site monograph (historical; not revalidated) (opens in a new tab)